Published in Antimicrob Agents Chemother on May 01, 1992
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother (1995) 2.01
Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol Mol Biol Rev (2002) 1.91
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds. Antimicrob Agents Chemother (1994) 1.29
Identification and overexpression in Escherichia coli of a Mycobacterium leprae gene, pon1, encoding a high-molecular-mass class A penicillin-binding protein, PBP1. J Bacteriol (1996) 1.10
Crystal structure of the Mycobacterium fortuitum class A beta-lactamase: structural basis for broad substrate specificity. Antimicrob Agents Chemother (2006) 0.90
Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitum beta-lactamase. Antimicrob Agents Chemother (1995) 0.82
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents. Antimicrob Agents Chemother (1995) 0.81
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria. Front Microbiol (2017) 0.79
Biochemical characterization of the 49 kDa penicillin-binding protein of Mycobacterium smegmatis. Biochem J (1996) 0.78
Altered permeability and beta-lactam resistance in a mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother (1997) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol (1973) 33.51
Properties of the penicillin-binding proteins of Escherichia coli K12,. Eur J Biochem (1977) 16.26
Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis (1985) 3.16
Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics. Rev Infect Dis (1986) 2.14
Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316. Biochem J (1990) 1.35
Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother (1985) 1.32
Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae. Antimicrob Agents Chemother (1991) 1.24
Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum. J Chemother (1989) 0.97
Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics. Antimicrob Agents Chemother (1991) 0.94
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother (1999) 9.01
Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother (2000) 5.26
Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother (1999) 4.24
An overview of the kinetic parameters of class B beta-lactamases. Biochem J (1993) 3.76
Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli. Antimicrob Agents Chemother (1999) 3.68
Cloning and nucleotide sequencing of the gene encoding the beta-lactamase from Citrobacter diversus. FEMS Microbiol Lett (1991) 3.24
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol (2001) 2.83
Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J (1998) 2.78
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds. Biochem J (1988) 2.61
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J Clin Microbiol (1999) 2.32
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production. Clin Microbiol Infect (2004) 2.11
Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry (1997) 2.11
Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase. Antimicrob Agents Chemother (2000) 2.08
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int (2006) 2.06
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol (2001) 1.92
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother (2002) 1.88
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol Microbiol (1994) 1.86
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
[Pseudopupil phenomena in the compound eye of drosophila]. Kybernetik (1971) 1.81
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-beta-lactamases. Antimicrob Agents Chemother (1995) 1.73
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases. Antimicrob Agents Chemother (1999) 1.70
The Legionella (Fluoribacter) gormanii metallo-beta-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 beta-lactamases. Antimicrob Agents Chemother (2000) 1.69
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Fluorescence of photoreceptor cells observed in vivo. Science (1981) 1.61
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
High specificity of cphA-encoded metallo-beta-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to beta-lactam resistance. Antimicrob Agents Chemother (1993) 1.59
Metallo-beta-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum. Antimicrob Agents Chemother (2001) 1.57
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerg Infect Dis (1997) 1.49
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (2001) 1.47
Evidence for a sensitising pigment in fly photoreceptors. Nature (1977) 1.43
Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain. Antimicrob Agents Chemother (1997) 1.42
TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother (2000) 1.41
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Biochemical characterization of the FEZ-1 metallo-beta-lactamase of Legionella gormanii ATCC 33297T produced in Escherichia coli. Antimicrob Agents Chemother (2001) 1.38
Citrobacter diversus ULA-27 beta-lactamases. Improved purification and general properties. Biochem J (1988) 1.38
Group B streptococci persist inside macrophages. Immunology (1998) 1.36
Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316. Biochem J (1990) 1.35
Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-beta-lactamase and VIM-2 metallo-beta-lactamase. Emerg Infect Dis (2001) 1.34
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
Extended-spectrum TEM- and SHV-type beta-lactamase-producing Klebsiella pneumoniae strains causing outbreaks in intensive care units in Italy. Eur J Clin Microbiol Infect Dis (2000) 1.32
PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy. Microb Drug Resist (2000) 1.32
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
The Aeromonas metallo-beta-lactamases: genetics, enzymology, and contribution to drug resistance. Microb Drug Resist (1996) 1.30
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60. Antimicrob Agents Chemother (1998) 1.29
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds. Antimicrob Agents Chemother (1994) 1.29
Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother (1996) 1.28
Fractionation and characterization of two beta-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing. J Chromatogr (1987) 1.27
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Infect Immun (1990) 1.25
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect Immun (1987) 1.24
Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis (1998) 1.23
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis (2012) 1.22
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
[In vivo optical study of photoreceptor elements in the compound eye of Drosophila]. Kybernetik (1971) 1.18
Citrobacter diversus ULA27 produces two forms of a chromosomal beta-lactamase. J Antimicrob Chemother (1987) 1.17
Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis (2007) 1.17
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun (1994) 1.16
Electrotransformation of Streptococcus agalactiae with plasmid DNA. FEMS Microbiol Lett (1994) 1.14
Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect Immun (1993) 1.12
Thiomandelic acid, a broad spectrum inhibitor of zinc beta-lactamases: kinetic and spectroscopic studies. J Biol Chem (2001) 1.12